Myovant is a California-based biotechnology company that develops and commercializes therapeutics for the treatment of fibroids, prostate cancer and infertility... Read more
Myovant is a California-based biotechnology company that develops and commercializes therapeutics for the treatment of fibroids, prostate cancer and infertility... Read more
News
Feb 21, 2025
Bloomberg Law
Myovant Sciences: Myovant Investor Claiming Skadden Conflict Denied Appellate Redo
Jan 30, 2025
Bloomberg Law
Myovant Sciences: Myovant Investor Fails to Revive Skadden Conflict Suit on Appeal
Oct 11, 2023
GlobalNewswire
Press Release: Myovant Sciences : SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
Sep 14, 2023
GlobalNewswire
Press Release: Myovant Sciences : Wohl & Fruchter LLP Has Filed a Class Action Lawsuit on Behalf of Former Shareholders of Myovant Sciences, Ltd. in the U.S. District Court for the Southern District of New York
Sep 14, 2023
Bloomberg Law
Myovant Sciences: Sumitomo Sued Over Skadden's Alleged Conflicts in Myovant Merger
Jun 26, 2023
StreetInsider
Press Release: Myovant Sciences : Health in Her HUE to Host Discussion Around Fibroids Awareness and Launch the Fibroids-focused Care Squad Program during Fibroid Awareness Month
May 17, 2023
FinanzNachrichten
Myovant Sciences: Myovant Sciences and Evidation Announce Survey Results of Unseen Burdens at Work and School of Individuals with Endometriosis and/or Uterine Fibroids
May 08, 2023
Myovant Sciences Youtube Channel
Myovant Sciences posted a video "What Is Shared Decision Making in the Doctor's Office?" on YOUTUBE
Apr 25, 2023
The Business Journals
Myovant Sciences: Myovant Sciences won 3 drug approvals and got bought out. Now it's cutting nearly 100 jobs.
Apr 04, 2023
StreetInsider
Press Release: Myovant Sciences : Sumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine and Form Sumitomo Pharma America
Myovant Sciences Competitors
1
2
3
4
5
6
7
8
9
10